Radiology, Vol 170, 435-440, Copyright © 1989 by Radiological Society of North America

ARTICLES

Residual mediastinal masses in Hodgkin disease: prediction of size with MR imaging

RS Nyman, SM Rehn, BL Glimelius, HE Hagberg, AL Hemmingsson and CJ Sundstrom
Department of Diagnostic Radiology, University of Uppsala, Sweden.

Eighteen patients with mediastinal involvement of Hodgkin disease were examined with magnetic resonance (MR) imaging before and during therapy to find out if size of residual masses could be predicted from the MR characteristics of the tumor at diagnosis. After the first treatment, a significant decrease in T2 values and signal intensity ratios of tumor to fat and tumor to muscle was found in all patients. There was no significant change in T1 values. The relative decrease in tumor size correlated well with signal intensity ratios and poorly with T2 values of the original tumor. No correlation with T1 values was found. The authors conclude that size of the residual mass can be predicted from the initial size of the tumor and the signal intensity ratios at diagnosis. Since the degree of low signal intensity in the tumor before treatment probably reflects the amount of fibrotic tissue, these results support the hypothesis that residual masses after treatment are remnants of the fibrotic stroma of the original tumor.

This article has been cited by other articles:

				T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]

				M. R. Weihrauch, D. Re, K. Scheidhauer, S. Ansen, M. Dietlein, S. Bischoff, H. Bohlen, J. Wolf, H. Schicha, V. Diehl, et al. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease Blood, November 15, 2001; 98(10): 2930 - 2934. [Abstract] [Full Text] [PDF]

				A. Rahmouni, M. Divine, E. Lepage, N. Jazaerli, K. Belhadj, P. Gaulard, M. Golli, F. Reyes, and N. Vasile Mediastinal Lymphoma: Quantitative Changes in Gadolinium Enhancement at MR Imaging after Treatment Radiology, June 1, 2001; 219(3): 621 - 628. [Abstract] [Full Text] [PDF]

				Q. Wang, S. Takashima, H. Fukuda, F. Takayama, S. Kobayashi, and S. Sone Detection of Medullary Thyroid Carcinoma and Regional Lymph Node Metastases by Magnetic Resonance Imaging Arch Otolaryngol Head Neck Surg, August 1, 1999; 125(8): 842 - 848. [Abstract] [Full Text] [PDF]

				G. Jerusalem, Y. Beguin, M.F. Fassotte, F. Najjar, P. Paulus, P. Rigo, and G. Fillet Whole-Body Positron Emission Tomography Using 18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin's Disease and Non-Hodgkin's Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging Blood, July 15, 1999; 94(2): 429 - 433. [Abstract] [Full Text] [PDF]